BACKGROUND: Usher syndrome (USH) is a clinically and genetically heterogeneous disease. The three recognised clinical phenotypes (types I, II and III; USH1, USH2 and USH3) are caused by mutations in nine different genes. USH2C is characterised by moderate to severe hearing loss, retinitis pigmentosa and normal vestibular function. One earlier report describes mutations in GPR98 (VLGR1) in four families segregating this phenotype. OBJECTIVE: To detect the disease-causing mutation in an Iranian family segregating USH2C. In this family, five members had a phenotype compatible with Usher syndrome, and two others had nonsyndromic hearing loss. METHODS: Mutation analysis of all 90 coding exons of GPR98. RESULTS: Consistent with these clinical findings, the five subjects with USH carried a haplotype linked to the USH2C locus, whereas the two subjects with nonsyndromic hearing loss did not. We identified a new mutation in GPR98 segregating with USH2C in this family. The mutation is a large deletion g.371657_507673del of exons 84 and 85, presumably leading to a frameshift. CONCLUSIONS: A large GPR98 deletion of 136 017 bp segregates with USH2C in an Iranian family. To our knowledge, this is only the second report of a GPR98 mutation, and the first report on male subjects with USH2C and a GPR98 mutation.
BACKGROUND:Usher syndrome (USH) is a clinically and genetically heterogeneous disease. The three recognised clinical phenotypes (types I, II and III; USH1, USH2 and USH3) are caused by mutations in nine different genes. USH2C is characterised by moderate to severe hearing loss, retinitis pigmentosa and normal vestibular function. One earlier report describes mutations in GPR98 (VLGR1) in four families segregating this phenotype. OBJECTIVE: To detect the disease-causing mutation in an Iranian family segregating USH2C. In this family, five members had a phenotype compatible with Usher syndrome, and two others had nonsyndromic hearing loss. METHODS: Mutation analysis of all 90 coding exons of GPR98. RESULTS: Consistent with these clinical findings, the five subjects with USH carried a haplotype linked to the USH2C locus, whereas the two subjects with nonsyndromic hearing loss did not. We identified a new mutation in GPR98 segregating with USH2C in this family. The mutation is a large deletion g.371657_507673del of exons 84 and 85, presumably leading to a frameshift. CONCLUSIONS: A large GPR98 deletion of 136 017 bp segregates with USH2C in an Iranian family. To our knowledge, this is only the second report of a GPR98 mutation, and the first report on male subjects with USH2C and a GPR98 mutation.
Authors: Inga Ebermann; Hendrik P N Scholl; Peter Charbel Issa; Elvir Becirovic; Jürgen Lamprecht; Bernhard Jurklies; José M Millán; Elena Aller; Diana Mitter; Hanno Bolz Journal: Hum Genet Date: 2006-12-15 Impact factor: 4.132
Authors: S Pieke-Dahl; C G Möller; P M Kelley; L M Astuto; C W Cremers; M B Gorin; W J Kimberling Journal: J Med Genet Date: 2000-04 Impact factor: 6.318
Authors: Sharon B Schwartz; Tomas S Aleman; Artur V Cideciyan; Elizabeth A M Windsor; Alexander Sumaroka; Alejandro J Roman; Tej Rane; Elaine E Smilko; Jean Bennett; Edwin M Stone; William J Kimberling; Xue-Zhong Liu; Samuel G Jacobson Journal: Invest Ophthalmol Vis Sci Date: 2005-02 Impact factor: 4.799
Authors: Khushnooda Ramzan; Rehan S Shaikh; Jamil Ahmad; Shaheen N Khan; Saima Riazuddin; Zubair M Ahmed; Thomas B Friedman; Edward R Wilcox; Sheikh Riazuddin Journal: Hum Genet Date: 2004-11-06 Impact factor: 4.132
Authors: J D Eudy; M D Weston; S Yao; D M Hoover; H L Rehm; M Ma-Edmonds; D Yan; I Ahmad; J J Cheng; C Ayuso; C Cremers; S Davenport; C Moller; C B Talmadge; K W Beisel; M Tamayo; C C Morton; A Swaroop; W J Kimberling; J Sumegi Journal: Science Date: 1998-06-12 Impact factor: 47.728
Authors: Frans P M Cremers; William J Kimberling; Maigi Külm; Arjan P de Brouwer; Erwin van Wijk; Heleen te Brinke; Cor W R J Cremers; Lies H Hoefsloot; Sandro Banfi; Francesca Simonelli; Johannes C Fleischhauer; Wolfgang Berger; Phil M Kelley; Elene Haralambous; Maria Bitner-Glindzicz; Andrew R Webster; Zubin Saihan; Elfride De Baere; Bart P Leroy; Giuliana Silvestri; Gareth J McKay; Robert K Koenekoop; Jose M Millan; Thomas Rosenberg; Tarja Joensuu; Eeva-Marja Sankila; Dominique Weil; Mike D Weston; Bernd Wissinger; Hannie Kremer Journal: J Med Genet Date: 2006-09-08 Impact factor: 6.318
Authors: Inga Ebermann; Jennifer B Phillips; Max C Liebau; Robert K Koenekoop; Bernhard Schermer; Irma Lopez; Ellen Schäfer; Anne-Francoise Roux; Claudia Dafinger; Antje Bernd; Eberhart Zrenner; Mireille Claustres; Bernardo Blanco; Gudrun Nürnberg; Peter Nürnberg; Rebecca Ruland; Monte Westerfield; Thomas Benzing; Hanno J Bolz Journal: J Clin Invest Date: 2010-05-03 Impact factor: 14.808
Authors: Maryam Beheshtian; Mojgan Babanejad; Hela Azaiez; Niloofar Bazazzadegan; Diana Kolbe; Christina Sloan-Heggen; Sanaz Arzhangi; Kevin Booth; Marzieh Mohseni; Kathy Frees; Mohammad Hossein Azizi; Ahmad Daneshi; Mohammad Farhadi; Kimia Kahrizi; Richard Jh Smith; Hossein Najmabadi Journal: Arch Iran Med Date: 2016-10-01 Impact factor: 1.354
Authors: Hideaki Moteki; Hidekane Yoshimura; Hela Azaiez; Kevin T Booth; A Eliot Shearer; Christina M Sloan; Diana L Kolbe; Toshinori Murata; Richard J H Smith; Shin-Ichi Usami Journal: Ann Otol Rhinol Laryngol Date: 2015-03-05 Impact factor: 1.547
Authors: Elodie M Richard; Regie Lyn P Santos-Cortez; Rabia Faridi; Atteeq U Rehman; Kwanghyuk Lee; Mohsin Shahzad; Anushree Acharya; Asma A Khan; Ayesha Imtiaz; Imen Chakchouk; Christina Takla; Izoduwa Abbe; Maria Rafeeq; Khurram Liaqat; Taimur Chaudhry; Michael J Bamshad; Deborah A Nickerson; Isabelle Schrauwen; Shaheen N Khan; Robert J Morell; Saba Zafar; Muhammad Ansar; Zubair M Ahmed; Wasim Ahmad; Sheikh Riazuddin; Thomas B Friedman; Suzanne M Leal; Saima Riazuddin Journal: Hum Mutat Date: 2018-11-18 Impact factor: 4.878